The FDA has approved atezolizumab with chemotherapy after surgery for stage III colon cancer with deficient mismatch repair, ...
We thank João Martins and Aneel Bhangu, Hermann Brenner and colleagues, and Uri Ladabaum and colleagues for their interesting comments on our report from the NordICC trial.1 We agree with Martins and ...
A new systematic review and meta-analysis of 45 studies shows that major abdominal surgery triggers rapid, clinically ...
Colorectal cancer most often spreads to the liver. When those liver tumors (called liver metastases) can be removed with ...
The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq) in combination with ...
Mayo Clinic says tt three years, 86.3% of patients who received immunotherapy plus chemotherapy were alive and free of ...
The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...
The FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer after the phase III ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq ® (atezolizumab) and Tecentriq Hybreza ® ...
Yale Medicine orthopaedic surgeon Dr. Daniel Wiznia explains how this joint-preserving procedure works, how successful it is, ...
Tampere University Hospital (Tays) has begun offering a new form of radiotherapy to treat rectal cancer in which a high dose ...
Burgess has survived colon cancer three times. She represents one of many instances of cancer rates surging in younger people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results